Cargando…
S115: CONSOLIDATION WITH BLINATUMOMAB IMPROVES OVERALL AND RELAPSE-FREE SURVIVAL IN PATIENTS WITH NEWLY DIAGNOSED B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT OF AGE AND MRD LEVEL IN ECOG-ACRIN E1910
Autores principales: | Litzow, Mark, Sun, Zhuoxin, Mattison, Ryan, Paietta, Elisabeth, Mullighan, Charles, Roberts, Kathryn, Zhang, Yanming, Racevskis, Janis, Willman, Cheryl, Wieduwilt, Matthew, Liedtke, Michaela, Bergeron, Julie, Lazarus, Hillard, Arber, Dan, Wood, Brent, Rowe, Jacob, Pratz, Keith, Dinner, Shira, Frey, Noelle, Gore, Steve, Bhatnagar, Bhavana, Atallah, Ehab, Uy, Geoff, Jeyakumar, Deepa, Lin, Tara, Patel, Shejal, Elliott, Michelle, Advani, Anjali, Deangelo, Daniel, Tzachanis, Dimitrios, Vachhani, Pankit, Bhave, Rupali, Little, Richard, Erba, Harry, Stone, Richard, Luger, Selina, Tallman, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428281/ http://dx.doi.org/10.1097/01.HS9.0000967372.19440.62 |
Ejemplares similares
-
CNS involvement in AML at diagnosis is rare and does not affect response or survival: data from 11 ECOG-ACRIN trials
por: Ganzel, Chezi, et al.
Publicado: (2021) -
At three years, patients with acute lymphoblastic leukaemia are still at risk for relapse. Results of the international MRC UKALLXII/ECOG E2993 trial
por: Ganzel, Chezi, et al.
Publicado: (2020) -
Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
por: Rapaport, Franck, et al.
Publicado: (2022) -
Correction: Integrative analysis identifies an older female-linked AML patient group with better risk in ECOG-ACRIN Cancer Research Group’s clinical trial E3999
por: Rapaport, Franck, et al.
Publicado: (2023) -
Bevacizumab’s Association With a Decreased Risk of Brain Metastases in ECOG-ACRIN E1505, a Phase 3 Randomized Trial of Adjuvant Chemotherapy With or Without Bevacizumab in Surgically Resected NSCLC
por: Varlotto, John M., et al.
Publicado: (2022)